Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome

Curr Atheroscler Rep. 2010 Mar;12(2):110-8. doi: 10.1007/s11883-010-0098-3.

Abstract

Metabolic syndrome is associated with increased propensity for diabetes and cardiovascular disease. Low-grade inflammation is characteristic of metabolic syndrome. C-reactive protein, the best characterized biomarker of inflammation, is also an independent predictor of future cardiovascular events. This review outlines the role of high-sensitivity C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome by inducing endothelial cell dysfunction and activating monocytes.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • C-Reactive Protein / metabolism*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • Disease Progression
  • Humans
  • Incidence
  • Inflammation / blood
  • Inflammation / complications
  • Metabolic Syndrome / blood*
  • Metabolic Syndrome / complications
  • Risk Factors

Substances

  • C-Reactive Protein